XRCC1 and female reproductive organ cancer: The relationship between XRCC1 polymorphism and susceptibility to gynecological malignant tumors has been reported for many times, but negative reports are also common.[57–60] Therefore, there is still no consensus on the relationship between XRCC1 polymorphism and gynecological malignant tumors.